LONDON--(BUSINESS WIRE)--The global selective serotonin reuptake inhibitors market is expected to post a CAGR of close to 4% during the period 2019-2023, according to the latest market research report ...
A new genetic and clinical analysis suggests that atypical depression represents a distinct biological subtype of the ...
Most of the available anti-depressant drugs do one thing: They selectively block reuptake. That is why they are called selective reuptake inhibitors. A drug that is a selective serotonin reuptake ...
When Prozac was introduced in 1987, it made a big splash as the first selective serotonin reuptake inhibitor (SSRI) antidepressant for the treatment of major depressive disorder. Prozac and Sarafem ...